semaglutide compound side effects FDA Warns on Certain Forms of Compounded Has semaglutide compound medication availability

doi: 10.1016/j.cmet.2018.03.001 3 MeierJJ

[DOI] [PubMed] [Google Scholar] 57.Seghieri M, Rebelos E, Gastaldelli A, Astiarraga BD, Casolaro A, Barsotti E, et al

Structural Insights into the Triple Agonism at GLP-1R, GIPR and GCGR Manifested by Retatrutide

Brand-name GLP-1 and GLP-1/GIP medicationsWegovy/Ozempic (semaglutide) and Mounjaro/Zepbound (tirzepatide)are FDA-approved for specific uses and require a medical evaluation

This triple-agonist profile distinguishes Retatrutide from virtually every other compound currently under active investigation

Glucagon-like peptide-1 (GLP-1) drugs are a class of drugs that work by imitating the actions of glucagon-like peptide-1 to stimulate insulin production